Anemia Management: Paradigm Shift or Hype?

8 Feb 2025 09:45 11:15
Amaltas Hall B101-B
DineshKhullar Chair India
Fatiu AbiolaArogundade Chair NigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria
MayuriTrivedi Chair IndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India

Session Description:
Anaemia is a common complication of kidney disease. Are the newer therapies any better than the old ones? In this session we will look at guideline-based therapy for anaemia and critically appraise the role of iron in its management.
Learning Objectives:
Discuss the guideline-based treatment of anaemia, Analyse the role of HIF-PHIS in the current management of anaemia. Review the role of iron and discuss consequences of iron overload.

Time Session
09:45
10:03
Guideline-based Treatment of Anaemia of CKD: What's New?
LF03-01
Kai-UweEckardt Speaker GermanyDepartment of Nephrology and Medical Intensive Car
10:03
10:21
HIF-PHIs: Two Sides of the Same Coin
LF03-02
Chuan-MingHao Speaker ChinaFudan University Huashan Hospital
10:21
10:39
Iron Therapy in CKD: Moving Targets
LF03-03
EviNagler Speaker evi.nagler@ugent.beBelgiumNephrology Department, Ghent University Hospital,
10:39
10:57
Consequences of Iron Overload
LF03-04
RobertKalyesubula Speaker UgandaMakerere, University
10:57
11:15
Q&A
LF03-05